Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31558890 | 1.00 | MAPT (0.47) | MAPTALDH1A1POLBSKP2MAPK1 | |
| SCHEMBL31457296 | 0.93 | CYP3A4 (0.48) | MAPTALDH1A1POLBSKP2MAPK1 | |
| SCHEMBL5377030 | 0.89 | MAPT (0.45) | MAPTALDH1A1POLBSKP2MAPK1 | |
| SCHEMBL5379527 | 0.87 | MAPT (0.44) | MAPTALDH1A1POLBSKP2CYP3A4 | |
| SCHEMBL5381219 | 0.85 | MAPT (0.42) | MAPTALDH1A1POLBSKP2CYP3A4 | |
| SCHEMBL3848692 | 0.83 | MAPT (0.65) | MAPTALDH1A1POLBMAPK1CYP3A4 | |
| SCHEMBL434003 | 0.83 | ALDH1A1 (0.44) | MAPTALDH1A1POLBSKP2MAPK1 | |
| SCHEMBL31457283 | 0.83 | CYP3A4 (0.45) | MAPTALDH1A1POLBSKP2MAPK1 | |
| SCHEMBL31457297 | 0.77 | MAPT (0.57) | MAPTALDH1A1POLBMAPK1CYP3A4 | |
| SCHEMBL5380955 | 0.77 | ALDH1A1 (0.45) | MAPTALDH1A1POLBSKP2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11203192-B2 | Matte finish polyimide films and methods relating thereto | E I DU PONT DE NEMOURS AND COMPANY (US) | 2021-12-21 | — | — | US | disclosed |
| US-10844184-B2 | Matte finish polyimide films and methods relating thereto | DUPONT ELECTRONICS, INC. (US) | 2020-11-24 | — | — | US | disclosed |
| US-20190263099-A1 | MATTE FINISH POLYIMIDE FILMS AND METHODS RELATING THERETO | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2019-08-29 | — | — | US | disclosed |
| US-10336045-B2 | Matte finish polyimide films and methods relating thereto | E I DU PONT DE NEMOURS AND COMPANY (US) | 2019-07-02 | — | — | US | disclosed |
| US-20180163006-A1 | MATTE FINISH POLYIMIDE FILMS AND METHODS RELATING THERETO | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2018-06-14 | — | — | US | disclosed |
| US-9926415-B2 | Matte finish polyimide films and methods relating thereto | E I DU PONT DE NEMOURS AND COMPANY (US) | 2018-03-27 | — | — | US | disclosed |
| US-20170174950-A1 | MATTE FINISH POLYIMIDE FILMS AND METHODS RELATING THERETO | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2017-06-22 | — | — | US | disclosed |
| US-9631054-B2 | Matte finish polyimide films and methods relating thereto | E I DU PONT DE NEMOURS AND COMPANY (US) | 2017-04-25 | — | — | US | disclosed |
| US-20160347933-A9 | PIGMENTED POLYIMIDE FILMS AND METHODS THERETO | E I DU PONT DE NEMOURS AND COMPANY (US) | 2016-12-01 | — | — | US | disclosed |
| US-20160137888-A1 | BONDPLY ADHESIVE COMPOSITION | E. I. DU PONT DE NEMOURS AND COMPANY | 2016-05-19 | — | — | US | disclosed |
| WO-2010101822-A1 | MULTILAYER FILM FOR ELECTRONIC CIRCUITRY APPLICATIONS AND METHODS RELATING THERETO | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-09-10 | — | — | WO | disclosed |
| US-7202359-B2 | Azaoxa heterocyclic compound and method of preparing the same | CHANG CHUN PLASTICS CO., LTD. (TW) | 2007-04-10 | — | — | US | disclosed |
| US-7084194-B2 | Halogen-free resin composition | CHANG CHUN PLASTICS CO., LTD. (TW) | 2006-08-01 | — | — | US | disclosed |
| CN-1234706-C | Nitrogen-oxygen heterocyclic compound and preparation method thereof | CHANGCHUN ARTIFICIAL RESIN FAC (CN) | 2006-01-04 | — | — | CN | disclosed |
| US-6900269-B2 | Halogen-free resin composition | CHANG CHUN PLASTICS CO., LTD. (TW) | 2005-05-31 | — | — | US | disclosed |
| US-20050085634-A1 | Azaoxa heterocyclic compound and method of preparing the same | CHANG CHUN PLASTICS CO., LTD. (TW) | 2005-04-21 | — | — | US | disclosed |
| US-20040158023-A1 | Halogen-free resin composition | CHANG CHUN PLASTICS CO., LTD. (TW) | 2004-08-12 | — | — | US | disclosed |
| US-20040147640-A1 | Halogen-free resin composition | CHANG CHUN PLASTICS CO., LTD. (TW) | 2004-07-29 | — | — | US | disclosed |
| CN-1490318-A | Nitrogen-oxygen heterocyclic compound and preparation method thereof | 长春人造树脂厂股份有限公司 | 2004-04-21 | — | — | CN | disclosed |
| US-20040068084-A1 | Azaoxa heterocyclic compound and method of preparing the same | CHANG CHUN PLASTICS CO., LTD. (TW) | 2004-04-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040068084-A1 | Azaoxa heterocyclic compound and method of preparing the same | AOX1, KDM1A, BMI1 | MAPT 2811/4885ALDH1A1 81/4885POLB 1238/4885 |
| US-20050085634-A1 | Azaoxa heterocyclic compound and method of preparing the same | AOX1, KDM1A, BMI1 | MAPT 2734/4885ALDH1A1 116/4885POLB 1310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.